New options for hard-to-treat breast cancer highlight SABCS
Presentations on new breast cancer research concluded today at the San Antonio Breast Cancer Symposium.
New studies on treatment options for triple negative breast cancer – an aggressive type of breast cancer with limited treatment options –were the highlight of studies released Friday.
Learn more from the day’s headlines:
2 Pre-Surgery Drug Treatments Show Promise Against Aggressive Breast Cancer
AbbVie drug shows promise against difficult type of breast cancer
In addition to new research, educational forums continued during the afternoon.
Baylor College of Medicine’s Dr. Xiang Zhang, assistant professor in the Lester and Sue Smith Breast Center, and Dr. Kent Osborne, SABCS co-director and director of the NCI-designated Dan L. Duncan Cancer Center and Sue Smith Breast Center, participated in talks on breast cancer metastasis and HER2-positive breast cancer.
Finally, a poster presentation from Baylor researchers revealing new information on a marker in breast cancer tissues and tumor-initiating cells was featured in the evening poster sessions.
Tomorrow the conference will officially end with a year-in-review talk by Osborne.
Miss a session or a headline from the conference? Read our highlights.
-By Glenna Picton
